Detailansicht

Wissensnetz

Person

Frank Erhard Uschner

Arzt

Name	Frank Erhard Uschner
Zeit	2020 (Wirkungsdaten)
Ort	Deutschland
Geschlecht	männlich
Beruf	Arzt (charakteristischer Beruf)
Variante	Frank Erhard Schulze (Geburtsname) (früherer Name) Frank Uschner
Beziehung	Rheinische Friedrich-Wilhelms-Universität Bonn
Weitere Angaben	Promotion an der Universität Bonn 2020
Datensatztyp	Person
GND-Nummer	1215212259
Datensatz-ID	1215212259
Beteiligt an alle anzeigen Use and outcome of TIPS in hospitalized patients in Germany: a nationwide study (2007–2018) Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure Extrahepatic surgery in cirrhosis significantly increases portal pressure in preclinical animal models Role of circulating angiogenin levels in portal hypertension and TIPS The sspecific NLRP3 antagonist IFM-514 decreases fibrosis and inflammation in experimental murine non-alcoholic steatohepatitis Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018) Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease Baseline presence of nafld predicts weight loss after gastric bypass surgery for morbid obesity Baseline presence of NAFLD predicts weight loss after gastric bypass surgery for morbid obesity Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction Die Effekte des Multikinase-Inhibitors Regorafenib auf die zirrhotische und nicht-zirrhotische portale Hypertension im Rattenmodell Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis Recent Advances in Practical Methods for Liver Cell Biology : A Short Overview Recent advances in practical methods for liver cell biology: a short overview Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview Short-term western diet aggravates non-alcoholic fatty liver disease (NAFLD) with portal hypertension in TGR(mREN2)27 rats The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology The role of macrophage-inducible c-type lectin in different stages of chronic liver disease Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Frank Erhard Uschner

Use and outcome of TIPS in hospitalized patients in Germany: a nationwide study (2007–2018)

Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure

Extrahepatic surgery in cirrhosis significantly increases portal pressure in preclinical animal models

Role of circulating angiogenin levels in portal hypertension and TIPS

The sspecific NLRP3 antagonist IFM-514 decreases fibrosis and inflammation in experimental murine non-alcoholic steatohepatitis

Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018)

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease

Baseline presence of nafld predicts weight loss after gastric bypass surgery for morbid obesity

Baseline presence of NAFLD predicts weight loss after gastric bypass surgery for morbid obesity

Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction

Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction

Die Effekte des Multikinase-Inhibitors Regorafenib auf die zirrhotische und nicht-zirrhotische portale Hypertension im Rattenmodell

Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis

Recent Advances in Practical Methods for Liver Cell Biology : A Short Overview

Recent advances in practical methods for liver cell biology: a short overview

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview

Short-term western diet aggravates non-alcoholic fatty liver disease (NAFLD) with portal hypertension in TGR(mREN2)27 rats

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

The role of macrophage-inducible c-type lectin in different stages of chronic liver disease

Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS